It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
What CimaVax is.
CimaVax EGF is a vaccine treatment being developed in Cuba for non small cell lung cancer. The vaccine targets a particular protein called epidermal growth factor (EGF). EGF occurs naturally in the body and signals to cells to grow and divide. It does this by attaching to a receptor protein on the cell surface. Some cancers make the body produce too much EGF so that the cells grow and divide uncontrollably.
The CimaVax vaccine is made up of two proteins, one of which is EGF. The vaccine works by stimulating the body’s immune response. It encourages the body to make antibodies that recognise and bind to EGF. This stops the EGF attaching to the receptors on cancer cells. So there is no signal telling the cancer cells to grow and divide. This slows the growth of the cancer.
n a pilot study in Cuba, all patients given the vaccine have had advanced non-small cell lung cancer. The study is ongoing. In a follow-up study, the 80 patients in the Canadian trial, which opened last September, are being randomized to get or not get the vaccine. Vincent is not sure of definitive results. “We may find,” he said, “that our end-stage people with non-small cell lung cancer do not mount an immune response to anything because they are too immuno-depressed. If so, we may need to move to a randomized study of the vaccine in patients with slightly less advanced disease.”
originally posted by: dogstar23
a reply to: christophoros
OP is a really long wall of text, so I'll just answer the headline of the thread:
Yes.
What is Cimavax?
Cimavax is a vaccine designed by Cuba’s Center for Molecular Immunology to help lung cancer patients by targeting a specific hormone that can encourage tumors to grow. The vaccine works by creating a protein in the body that primes the immune system to attack a hormone called epidermal growth factor (EGF), a naturally occurring hormone in the body.
"The idea is that ... the Cimavax vaccine induces a immune response" to stop EFG production, explained Lee. "The tumor is being starved."
CimaVax, which is both a treatment and vaccine for lung cancer, has been researched in Cuba for 25 years and free to the Cuban public since 2011.
The difficulty, he said, was that “our [Canadian] patients are somewhat different from those in Cuba in that they have had chemotherapy of a different sort and may be at a different point in their natural history [of non-small cell lung cancer].”
Anyway, BP wants to make kratom illegal. It's taking money from their pockets.
The CimaVax vaccine is made up of two proteins, one of which is EGF. The vaccine works by stimulating the body’s immune response. It encourages the body to make antibodies that recognise and bind to EGF. This stops the EGF attaching to the receptors on cancer cells. So there is no signal telling the cancer cells to grow and divide. This slows the growth of the cancer.